Sex-Based Differences in Revascularization Outcomes: Is It Time for a Dedicated Randomized Trial in Women?
作者信息
Malick Waqas A, Soriano Kevin, Stone Gregg W
机构信息
The Zena and Michael A. Wiener Cardiovascular Institute Icahn School of Medicine at Mount Sinai New York NY.
Clinical Trials Center Cardiovascular Research Foundation New York NY.
出版信息
J Am Heart Assoc. 2022 Mar;11(5):e024281. doi: 10.1161/JAHA.121.024281. Epub 2022 Feb 22.
Abstract
摘要
相似文献
1
Sex-Based Differences in Revascularization Outcomes: Is It Time for a Dedicated Randomized Trial in Women?血运重建结果中的性别差异：是时候开展一项针对女性的专门随机试验了吗？
J Am Heart Assoc. 2022 Mar;11(5):e024281. doi: 10.1161/JAHA.121.024281. Epub 2022 Feb 22.
2
Sex Differences in Outcomes After Percutaneous Coronary Intervention or Coronary Artery Bypass Graft for Left Main Disease: From the DELTA Registries.左主干疾病行经皮冠状动脉介入治疗或冠状动脉旁路移植术的性别差异：来自 DELTA 注册研究。
J Am Heart Assoc. 2022 Mar;11(5):e022320. doi: 10.1161/JAHA.121.022320. Epub 2022 Feb 22.
3
Outcomes After Coronary Stenting or Bypass Surgery for Men and Women With Unprotected Left Main Disease: The EXCEL Trial.男性和女性无保护左主干病变患者行冠状动脉支架置入术或旁路手术的结果：EXCEL 试验。
JACC Cardiovasc Interv. 2018 Jul 9;11(13):1234-1243. doi: 10.1016/j.jcin.2018.03.051.
4
Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.冠状动脉血运重建术后卒率比较：外科手术与经皮冠状动脉介入治疗。
J Am Coll Cardiol. 2018 Jul 24;72(4):386-398. doi: 10.1016/j.jacc.2018.04.071.
5
Geographical Difference of the Interaction of Sex With Treatment Strategy in Patients With Multivessel Disease and Left Main Disease: A Meta-Analysis From SYNTAX (Synergy Between PCI With Taxus and Cardiac Surgery), PRECOMBAT (Bypass Surgery Versus Angioplasty Using Sirolimus-Eluting Stent in Patients With Left Main Coronary Artery Disease), and BEST (Bypass Surgery and Everolimus-Eluting Stent Implantation in the Treatment of Patients With Multivessel Coronary Artery Disease) Randomized Controlled Trials.多支血管病变和左主干疾病患者中治疗策略与性别的相互作用的地理差异：来自 SYNTAX（紫杉醇与心脏手术的协同作用）、PRECOMBAT（左主干冠状动脉疾病患者中使用西罗莫司洗脱支架的旁路手术与血管成形术比较）和 BEST（多支血管冠状动脉疾病患者中旁路手术和依维莫司洗脱支架植入的比较）随机对照试验的荟萃分析。
Circ Cardiovasc Interv. 2017 May;10(5). doi: 10.1161/CIRCINTERVENTIONS.117.005027.
6
Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.药物洗脱支架经皮冠状动脉介入治疗与旁路手术治疗 3 支血管病变或左主干病变患者的成本效益：紫杉醇药物洗脱支架与心脏手术（SYNTAX）试验的最终结果。
Circulation. 2014 Sep 30;130(14):1146-57. doi: 10.1161/CIRCULATIONAHA.114.009985. Epub 2014 Aug 1.
7
A comparative study of bypass versus percutaneous intervention for left main disease.左主干病变搭桥术与经皮介入治疗的对比研究。
Tunis Med. 2019 Apr;97(4):533-540.
8
Percutaneous Coronary Intervention of Left Main Disease: Pre- and Post-EXCEL (Evaluation of XIENCE Everolimus Eluting Stent Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization) and NOBLE (Nordic-Baltic-British Left Main Revascularization Study) Era.左主干疾病的经皮冠状动脉介入治疗：EXCEL（评价依维莫司洗脱支架 XIENCE 与冠状动脉旁路移植术治疗左主干血运重建效果）和 NOBLE（北欧-波罗的海-英国左主干血运重建研究）时代之前和之后。
Circ Cardiovasc Interv. 2017 Jun;10(6). doi: 10.1161/CIRCINTERVENTIONS.117.004792.
9
Percutaneous Coronary Intervention or Surgery for Unprotected Left Main Disease: EXCEL Trial at 5 Years.经皮冠状动脉介入治疗或手术治疗无保护左主干病变：EXCEL 试验 5 年随访结果
Interv Cardiol Clin. 2020 Oct;9(4):419-432. doi: 10.1016/j.iccl.2020.05.002. Epub 2020 Aug 12.
10
Contemporary Outcomes Following Coronary Artery Bypass Graft Surgery for Left Main Disease.左主干病变行冠状动脉旁路移植术后的当代结局。
J Am Coll Cardiol. 2019 Apr 23;73(15):1877-1886. doi: 10.1016/j.jacc.2018.12.090.
本文引用的文献
1
Time-Dependent Impact of Sex on the Long-Term Outcomes After Left Main Revascularization.时间依赖性性别对左主干血运重建后长期结局的影响。
J Am Heart Assoc. 2022 Mar;11(5):e021720. doi: 10.1161/JAHA.121.021720. Epub 2022 Feb 22.
2
External Validation of the SYNTAX Score II 2020.SYNTAX Score II 2020 外部验证
J Am Coll Cardiol. 2021 Sep 21;78(12):1227-1238. doi: 10.1016/j.jacc.2021.07.027.
3
Sex Differences in All-Cause Mortality in the Decade Following Complex Coronary Revascularization.复杂冠状动脉血运重建后十年全因死亡率的性别差异。
J Am Coll Cardiol. 2020 Aug 25;76(8):889-899. doi: 10.1016/j.jacc.2020.06.066.
4
Ten-Year Outcomes After Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Left Main Coronary Disease: Extended Follow-Up of the PRECOMBAT Trial.药物洗脱支架与冠状动脉旁路移植术治疗左主干病变的 10 年结果：PRECOMBAT 试验的扩展随访。
Circulation. 2020 May 5;141(18):1437-1446. doi: 10.1161/CIRCULATIONAHA.120.046039. Epub 2020 Mar 30.
5
Mortality after drug-eluting stents vs. coronary artery bypass grafting for left main coronary artery disease: a meta-analysis of randomized controlled trials.药物洗脱支架与冠状动脉旁路移植术治疗左主干冠状动脉疾病的死亡率：随机对照试验的荟萃分析。
Eur Heart J. 2020 Sep 7;41(34):3228-3235. doi: 10.1093/eurheartj/ehaa135.
6
Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial.经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗无保护左主干狭窄：NOBLE 随机非劣效性试验的 5 年更新结果。
Lancet. 2020 Jan 18;395(10219):191-199. doi: 10.1016/S0140-6736(19)32972-1. Epub 2019 Dec 23.
7
Nonproportional Hazards for Time-to-Event Outcomes in Clinical Trials: JACC Review Topic of the Week.临床试验中事件时间终点的非比例风险：JACC 每周综述专题。
J Am Coll Cardiol. 2019 Oct 22;74(16):2102-2112. doi: 10.1016/j.jacc.2019.08.1034.
8
Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease.左主干冠状动脉疾病经皮冠状动脉介入治疗或冠状动脉旁路移植术后 5 年的结果。
N Engl J Med. 2019 Nov 7;381(19):1820-1830. doi: 10.1056/NEJMoa1909406. Epub 2019 Sep 28.
9
Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial.经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗三血管病变或左主干病变患者：多中心随机对照 SYNTAX 试验 10 年随访结果。
Lancet. 2019 Oct 12;394(10206):1325-1334. doi: 10.1016/S0140-6736(19)31997-X. Epub 2019 Sep 2.
10
Effect of Age and Sex on Outcomes After Stenting or Bypass Surgery in Left Main Coronary Artery Disease.年龄和性别对左主干冠状动脉疾病支架置入或旁路手术后结局的影响。
Am J Cardiol. 2019 Sep 1;124(5):678-687. doi: 10.1016/j.amjcard.2019.05.061. Epub 2019 Jun 6.
Zotero 插件